• Thapsigargin as a Quantitative Benchmark for ER Stress and C

  2026-04-21

  Explore how Thapsigargin, a leading SERCA pump inhibitor, enables precise quantification of calcium homeostasis disruption and endoplasmic reticulum stress in advanced cellular models. This article uniquely focuses on quantitative benchmarking for apoptosis and ER stress assays, offering guidance for robust, reproducible research.

• Autophagy–Metastasis Prognostic Signature in Colorectal Canc

  2026-04-21

  Bai et al. present a prognostic signature for colorectal cancer (CRC) that integrates autophagy- and liver metastasis-related gene expression from bulk and single-cell transcriptomic data. Their approach enhances the prediction of patient risk and immune microenvironment features, offering new perspectives for targeted therapies and patient stratification.

• Bleomycin Sulfate: Optimizing Pulmonary Fibrosis and DNA Dam

  2026-04-20

  Bleomycin Sulfate (Blenoxane) is the gold-standard reagent for modeling chemotherapy-induced DNA damage and pulmonary fibrosis. This guide delivers actionable workflows, troubleshooting tactics, and experimental insights that empower researchers to extract maximum mechanistic fidelity and reproducibility from their fibrosis, oncology, and cell injury assays.

• Transdermal PTEN mRNA Delivery via HA-LNPs for Melanoma Immu

  2026-04-20

  This study introduces a hyaluronate-lipid nanoparticle (HA-LNP) system for the transdermal delivery of PTEN mRNA, aiming to restore tumor suppressor function in melanoma. The research demonstrates that HA-LNP-mediated PTEN mRNA delivery can effectively inhibit tumor growth and enhance immune activation, providing a promising strategy for localized mRNA-based cancer immunotherapy.

• Propranolol as a Non-Selective β-Adrenergic Receptor Blocker

  2026-04-19

  Propranolol’s broad utility as a non-selective β-adrenergic receptor blocker makes it a cornerstone for cardiovascular regulation, emotional memory modulation, and essential tremor therapy studies. Explore protocol-anchored workflows, real-world troubleshooting, and the latest comparative insights to maximize experimental reliability with APExBIO’s Propranolol.

• N6-Methyl-dATP: Precision Tool for Epigenetic and Replicatio

  2026-04-18

  N6-Methyl-dATP empowers researchers to interrogate DNA replication fidelity and dissect methylation-dependent regulation with unmatched specificity. This article translates cutting-edge AML research into actionable protocols, advanced troubleshooting, and workflow enhancements driven by APExBIO's high-purity N6-Methyl-2'-deoxyadenosine-5'-Triphosphate.

• Bestatin Hydrochloride in Cancer & Neurobiology: Applied Wor

  2026-04-17

  Bestatin hydrochloride (Ubenimex) is a potent tool for dissecting aminopeptidase-regulated processes in cancer and neuroscience, offering robust control over angiogenesis and tumor invasion. This guide explores advanced workflows, protocol refinements, and troubleshooting strategies to maximize experimental value with APExBIO's Bestatin hydrochloride.

• Captopril in Integrated Vascular and Gastrointestinal Resear

  2026-04-16

  Explore the precise role of Captopril as a benchmark ACE inhibitor in both vascular and gastrointestinal research. This article uniquely analyzes ACE-bradykinin interactions, advanced protocol design, and the translational potential for apoptosis studies, providing practical guidelines for high-impact research.

• Nonconventional Agonist-Antagonist Interplay at the GLP-1R R

  2026-04-15

  Chepurny et al. (2019) reveal that glucagon can act as a non-traditional agonist at the GLP-1 receptor, with complex interactions among agonists and antagonists uncovered using high-throughput FRET-based cAMP assays. These findings challenge established assumptions of selectivity in GLP-1 and glucagon receptor pharmacology, with broad implications for metabolic and diabetes research.

• AP20187 as a Precision Modulator in Conditional Gene Therapy

  2026-04-14

  Explore how AP20187, a leading chemical inducer of dimerization, enables targeted control of signaling in conditional gene therapy. This article uncovers unique mechanistic insights and advanced assay optimization strategies not covered elsewhere.

• Practical Use of Cy3 Rabbit Anti-Goat IgG (H+L) Antibody (K1

  2026-04-13

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody is designed for researchers needing reliable, sensitive detection of goat IgG in fluorescence-based assays. It is best suited for immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA where goat primary antibodies are used. It is not appropriate for detection of non-goat immunoglobulins or for non-fluorescent detection formats.

• Ademetionine in Neurological Disorders: Methylation and CNS

  2026-04-12

  This review by Bottiglieri et al. synthesizes the biochemical and clinical evidence for ademetionine (S-adenosylmethionine, SAMe) as a key methyl donor in central nervous system disorders. It highlights SAMe’s roles in methylation reactions relevant to neurotransmitter metabolism, antidepressant activity, and dementia, offering mechanistic and translational insights for neuropsychiatric research.

• L-NAME Hydrochloride in NO Pathway Dissection and Hypertensi

  2026-04-12

  Explore the distinct applications of L-NAME Hydrochloride, a potent NOS inhibitor, in unraveling nitric oxide signaling and hypertension models. This article delivers advanced scientific insight and practical guidance for experimental design beyond standard protocols.

• Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) in Tr

  2026-04-11

  Leverage Ibuprofen’s COX-1/COX-2 inhibition and anti-proliferative action to dissect apoptosis and cell cycle arrest in colon cancer research. This article delivers rigorous, protocol-driven guidance and troubleshooting strategies for maximizing the impact of APExBIO’s Ibuprofen in advanced cell-based and in vivo workflows.

• AZ505: SMYD2 Inhibitor Unlocks New Horizons in Epigenetics

  2026-04-11

  AZ505, a potent SMYD2 inhibitor from APExBIO, enables precise, substrate-competitive epigenetic modulation in cancer and fibrosis models. Recent breakthroughs showcase its ability to dissect SMYD2-driven pathways, optimize disease modeling, and overcome common assay pitfalls.

453 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page